DYADIC INTERNATIONAL INC Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
DYADIC INTERNATIONAL INC (DYAI) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $291.41 thousand as of 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-03-25
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $291.41K.
- 2024-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $319.98K.
- 2023-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $559.12K.
- 2022-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $919.00K.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount as first filed |
|---|---|---|
| 2025-12-31 | $291.41K 10-K · filed 2026-03-25 | |
| 2024-12-31 | $319.98K 10-K · filed 2026-03-25 | |
| 2023-12-31 | $559.12K 10-K · filed 2025-03-26 | |
| 2022-12-31 | $919.00K 10-K · filed 2024-03-28 | |
| 2021-12-31 | $857.00K 10-K · filed 2023-03-29 | $856.98K 10-K · filed 2022-03-29 |
| 2020-12-31 | $477.23K 10-K · filed 2022-03-29 | |
| 2019-12-31 | $222.33K 10-K · filed 2021-03-30 | |
| 2018-12-31 | $162.79K 10-K · filed 2020-03-30 | |
| 2017-12-31 | $211.01K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |